United States

Who we are

February 24, 2025
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
October 15, 2024
Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)
October 14, 2024
A Study of AK112 With or Without AK117 in Metastatic Colorectal Cancer
August 23, 2024
A Dose Escalation Study of AV-380 in Metastatic Cancer Patients With Cachexia
July 8, 2024
Nous-209 Genetic Vaccine for the Treatment of Microsatellite Unstable Solid Tumors
June 28, 2024
Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer
June 23, 2024
Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01)
April 24, 2024
Platform Study of Immunotherapy Combinations in Colorectal Cancer Liver Metastases
April 24, 2024
A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors
April 19, 2024
Botensilimab Plus Balstilimab and Fasting Mimicking Diet Plus Vitamin C for Patients With KRAS-Mutant Metastatic Colorectal Cancer